Evaluation of hydralazine and procainamide effects on fibroblast membrane fluidity

Biochimie

Volumn 85, Issue 5, 2003, Pages 549-556

  Weglarz, Ludmiła ^a   Koceva Chyła, Aneta ^b   Gwoździński, Krzysztof ^b   Dzierzewicz, Zofia ^a   Jóźwiak, Zofia ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Fibroblasts; Hydralazine; Membrane fluidity; Procainamide

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; HYDRALAZINE; PROCAINAMIDE; STEARIC ACID;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL LINE; CELL MEMBRANE FLUIDITY; CELL POLARITY; CELL STRAIN 3T3; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ELECTRON SPIN RESONANCE; FIBROBLAST; FLUIDIZATION; FLUORESCENCE SPECTROSCOPY; HAMSTER; HYDROPHOBICITY; LIPID BILAYER; MOUSE; NONHUMAN; RIGIDITY; SPIN LABELING;

CRICETINAE;

EID: 0038532454     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00033-6     Document Type: Article

References (42)

1. A. Tangorra, G. Curatola, E. Bertoli, Evaluation of antiepileptic drug effect on membrane fluidity, Exp. Mol. Pathol. 55 (1991) 180-189.
2. D.B. Goldstein, The effect of drugs on membrane fluidity, Ann. Rev. Pharmacol. Toxicol. 24 (1984) 43-64.
3. M. Jedrzejczak, A. Koceva-Chyła, K. Gwoździński, Z. Jóźwiak, Changes in plasma membrane fluidity of immortal rodent cells induced by anticancer drugs doxorubicin, aclarubicin and mitoxantrone, Cell Biol. Int. 23 (1999) 497-506.
4. G. Curatola, G. Lenaz, Role of plasma membrane fluidity in the regulation of cellular activities, in: N. Akkas (Ed.), Biomechanics of Cell Division, Plenum, New York, 1987, pp. 33-77.
5. R. Regev, Y.G. Assaraf, G.D. Eytan, Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells, Eur. J. Biochem. 259 (1999) 18-24.
6. H. Schuldes, J. Dolderer, J. Knobloch, S. Bade, R. Bickeboller, B.G. Woodcock, D. Jonas, G. Zimmer, Relationship between plasma membrane fluidity and R-verapamil action in CHO cells, Int. J. Clin. Pharmacol. Ther. 36 (1998) 71-73.
7. E. Beccerica, G. Ferretti, G. Curatola, C. Cervini, Diacetylrhein and rhein: In vivo and in vitro effect on lymphocyte membrane fluidity, Pharmacol. Res. 22 (1990) 277-285.
8. T.R. Tritton, J.A. Hickman, Cells surface membranes as chemotherapeutic target, in: F.M. Muggia (Ed.), Experimental and Clinical Progress in Cancer Chemotherapy, Martinus Nijhoff Publishers, Boston, 1985, pp. 81-131.
9. B. Bonnekoh, J. Roding, G.R.F. Krueger, M. Ghyczy, G. Mahrle, Increase of lipid fluidity and suppression of proliferation resulting from liposome uptake by human keratinocytes in vitro, Br. J. Dermatol. 124 (1989) 333-340.
10. A. Hermetter, B. Rainer, E. Ivessa, E. Kalb, J. Loidl, A. Roshner, F. Paltauf, Influence of plasmalogen deficiency on membrane fluidity of human skin fibroblasts: A fluorescence anisotrophy study, Biochim. Biophys. Acta 978 (1989) 151-157.
11. G. Lenaz, Membrane fluidity and its alterations in disease, in: G. Benga, J.M. Tager (Eds.), Biomembranes: Basic and Medical Research, Springer, Berlin, 1988, pp. 13-49.
12. S.C. Jones, T.H. Thomas, S.M. Marshall, Abnormal regulation of cell membrane fluidity in diabetic nephropathy, Dibetology 41 (1998) 337-342.
13. O. Simonetti, G. Ferretti, A.M. Offidani, P. Gervasi, G. Curatola, G. Bossi, Plasma membrane fluidity of keratinocytes of normal and psoriatic skin: A study using fluorescence anisotrophy of trimethylammoniumdiphenylhexatriene (TMA-DPH), Arch. Dermatol. Res. 288 (1996) 51-54.
14. R.B. Scott, J.M. Collins, P.A. Hunt, Alzheimer's disease and Down syndrome: Leukocyte membrane fluidity alterations, Mech. Ageing Dev. 75 (1994) 1-10.
15. A. Kantar, P.L. Giorgi, G. Curatola, R. Fiorini, Alterations in membrane fluidity of diabetic polymorphonuclear leukocytes, Biochem. Med. Metab. Biol. 46 (1991) 422-426.
16. M. Donner, S. Muller, J.F. Stolz, Importance of membrane fluidity determinations, J. Mal. Vasc. 15 (1990) 353-358.
17. K. Tsuda, Y. Kinoshita, I. Nishio, Y. Masuyama, Adrenomedullin and membrane fluidity of erythrocytes in mild essential hypertension, J. Hypertens. 17 (1999) 201-210.
18. M.M. Guffy, J.A. North, C.P. Burns, Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L 1210 murine leukemia cells, Cancer Res. 44 (1984) 1863-1866.
19. J. Uetrecht, Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions, Crit. Rev. Toxicol. 20 (1990) 213-234.
20. R.L. Rubin, Autoimmune reactions induced by procainamide and hydralazine, in: M.E. Kammuler, N. Bloksma, W. Seinen (Eds.), Autoimmunity and Toxicology. Immune Disregulation Induced by Drugs and Chemicals, Elsevier Science Publishers B.V., Amsterdam, New York, Oxford, 1989, pp. 119-150.
21. C. Goebel, C. Vogel, M. Wulferink, S. Mitman, B. Sachs, S. Schraa, J. Abel, G. Degen, J. Uetrecht, E. Gleichmann, Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages, Chem. Res. Toxicol. 12 (1999) 488-500.
22. A. Litwin, L.E. Adams, H. Zimmer, B. Foad, J.H.M. Loggie, E.V. Hess, Prospective study of immunologic effects of hydralazine in hypertensive patients, Clin. Pharmacol. Ther. 29 (1981) 447-456.
23. B.K. Sinha, M.A. Patterson, Free radical metabolism of hydralazine. Binding and degradation of nucleic acids, Biochem. Pharmacol. 32 (1983) 3279-3284.
24. L. Weglarz, G. Bartosz, Hydralazine stimulates production of oxygen free radicals in Eagle's medium and cultured fibroblasts, Free Radic. Biol. Med. 11 (1991) 149-155.
25. K. Yamamoto, S. Kawanishi, Free radical production and site-specific DNA damage induced by hydralazine in the presence of metal ions or peroxidase/hydrogen peroxide, Biochem. Pharmacol. 41 (1991) 905-914.
26. L. Weglarz, A. Koceva-Chyła, M. Drózdz, Z. Jóźwiak, Single-strand breaks and repair in nuclear DNA in the presence of hydralazine assayed by the nucleoid technique, Biochem. Mol. Biol. Int. 43 (1997) 513-519.
27. L. Weglarz, A. Koceva-Chyła, Changes in DNA supercoiling in fibroblasts cultured in the presence of hydralazine, Biochimie 80 (1998) 627-630.
28. R.L. Rubin, J.P. Uetrecht, J.E. Jones, Cytotoxicity of oxidative metabolites of procainamide, J. Pharmacol. Exp. Ther. 242 (1987) 833-841.
29. J.G. Kuhry, G. Duportail, C. Bronner, G. Laustriat, Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene, Biochim. Biophys. Acta 845 (1985) 60-67.
30. B.W. Van Der Meer, Fluorescence studies on biological membranes, in: H.J. Hilderson, J.R. Harris (Eds.), Subcellular Biochemistry, vol. 13, Plenum Press, New York, 1988, pp. 1-53.
31. L. Stuhne-Sekalec, N.Z. Stanacev, Temperature-induced changed spin-labeled radioactive lipids in isolated guinea pig liver microsomal membranes before and in mitochondrial membranes after translocation, Can. J. Biochem. 56 (1978) 722-728.
32. T. Mossman, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63.
33. J. Matko, P. Nagy, Fluorescent lipid probes 12-AS and TMA-DPH report on selective, purinergically induced fluidity changes in plasma membranes of lymphoid cells, J. Photochem. Photobiol. B. Biol. 40 (1997) 120-125.
34. E. Cornacchia, J. Golbus, J. Maybaum, J. Strahler, S. Hanash, B. Richardson, Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity, J. Immunol. 140 (1988) 2197-2200.
35. L. Weglarz, A. Koceva-Chyła, Z. Jóźwiak, Plasma membrane fluidity studies by fluorescence anisotropy in fibroblasts incubated with hydralazine, Curr. Top Biophys. 22 (suppl. B) (1998) 225-229.
36. L. Weglarz, Free radical mechanisms of genotoxic effects of hydralazine on the induction of immunogenicity of DNA in in vitro and in vivo studies (in Polish), Ann. Acad. Med. Siles. Katowice 181 (1994).
37. R. Bruch, W.S. Thayer, Differential effect of lipid peroxidation on membrane fluidity as determined by electron spin resonance probes, Biochim. Biophys. Acta 733 (1983) 216-222.
38. H. Bolhuis, H.W. Van Veen, D. Molenaar, B. Poolman, A.J. Driessen, W.N. Konings, Multidrug resistance in Lactococcus lactis: Evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane, EMBO J. 15 (1990) 4239-4245.
39. E.R. Block, Hydrogen peroxide alters the physical state and function of the plasma membrane of pulmonary artery endothelial cells, J. Cell. Physiol. 146 (1991) 362-369.
40. J.P. Uetrecht, Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide, J. Pharmacol. Exp. Ther. 232 (1985) 420-425.
41. D. Jourd'heuil, A. Aspinall, J.D. Reynolds, J.B. Meddings, Membrane fluidity increases during apoptosis of sheep ileal Peyer's fluidity patch B cells, Can. J. Physiol. Pharmacol. 74 (1996) 706-711.
42. C.L. Leger, D. Daveloose, R. Christon, J. Viret, Evidence for a structurally specific role of essential polyunsaturated fatty acids depending on their peculiar double-bond distribution in biomembranes, Biochemistry 29 (1990) 7269-7275.